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Abstract We report a case of a 55-year-old immuno-
compromised female who presented to the emergency
department with severe diarrhea and vomiting following
travel to the Philippines. Stool bacteriology revealed a
mixed infection involving an enteropathogenic Escherichia
coli and two distinct strains of enteroaggregative Esche-
richia coli (EAEC). During hospitalization, urine and
blood culture tested positive for one of the diarrheagenic
EAEC strains, necessitating urinary catheterization, inten-
sive care, and antimicrobial treatment with trimethoprim–
sulfamethoxazole, followed by meropenem. Although
known to occasionally cause urinary tract infections,
EAEC have not been previously associated with sepsis.
Our report highlights the potential of EAEC to cause severe
extraintestinal infections.
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Introduction
Enteroaggregative Escherichia coli (EAEC) is recognized
as an etiological agent of acute and persistent diarrhea in
people in developing countries and in travelers visiting less
developed areas of the world, as well as in immunocom-
promised individuals [1, 2]. In addition, the pathogenic
potential of EAEC has been demonstrated by the emer-
gence of food-borne outbreaks, most notably in Germany
in 2011 [3]. Recently, EAEC has been associated with an
outbreak of urinary tract infections [4], emphasizing the
need to increase understanding of the extraintestinal
properties of EAEC. Here, we describe the case of a
diarrheal EAEC associated with urinary tract infection and
bacteremia leading to sepsis, and characterize this isolate
by its adherence pattern to HEp-2 cells, pulsed-field gel
electrophoresis (PFGE), virulence and virulence-associated
gene analysis, serotyping, multilocus sequence typing
(MLST), and antibiotic susceptibility testing.
Case presentation
A 55-year-old woman was admitted to the emergency unit
of her local general hospital because of persistent diarrhea
and vomiting. The patient, immunosuppressed [Tacrolimus
(Prograf) 0.5 mg 29/day, Mycophenolate Mofetil (Cell-
Cept) 500 mg 29/day] since a renal transplantation
7 years previously, was well until 15 days prior to admis-
sion, when gastroenteritic symptoms started 5 days after
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she returned from Manila. She was hemodynamically sta-
ble, but hypotonic, dehydrated, and anuric as of 3 days
before admission. Urinary catheterization was initiated
upon admission. Her blood pressure was 86/44 mmHg, her
pulse was 66/min, and her white blood cell count (WBC)
was 11.6 9 109/l. Moreover, her serum creatinine was
1,212 lmol/l (13.7 mg/dl), serum urea was 35.6 mmol/l
(99.7 mg/dl), glomerular filtration rate (GFR) was
3.4 ml/min, and phosphorus was 3.6 mmol/l (11.1 mg/dl),
so continuous venovenoushemodialysis and filtration
(CVVHDF) was started. No blood culture but a urine
culture was drawn upon admission, yielding 104 colony-
forming units (CFU)/ml by three different contaminating
bacteria. Despite the anuric kidney failure, a low serum
potassium value of 2.7 mmol/l (10.5 mg/dl) was observed,
consistent with the severe and long-standing gastroenteri-
tis. Substitution of liquids and electrolytes was initiated,
and dialysis was stopped on day 1, when renal function
resumed. Standard bacteriology [5] of three stool samples
performed between day 4 and day 5 yielded negative
results concerning the Salmonella, Shigella, Campylobac-
ter, Mycobacterium sp., as well as for theenzyme-linked
immunosorbent assay (Novitec, HiSS Diagnostics GmbH,
Freiburg, Germany) used for detecting Clostridium difficile
toxins A/B. Parasitological analysis revealed Blastocystis
hominis, a facultative pathogen. Gastroscopy and colon-
oscopy on day 4 showed erosive gastritis and unspecific
inflammation of the colon. Biopsies revealed eosinophilic
ileitis and colitis, but no pathogen. Consequently, antipar-
asitic therapy with metronidazole was administered on day
5. On day 6, a further stool sample was analyzed by mul-
tiplex polymerase chain reaction (PCR) for diarrheagenic
E. coli (DEC), including enteropathogenic (EPEC), en-
teroaggregative (EAEC), Shiga toxin-producing (STEC),
enteroinvasive (EIEC), and enterotoxic E. coli (ETEC),
using the commercial E. coli DEC Primer Mix (Statens
Serum Institut, Hillerød,Denmark). In addition, single
PCRs aimed at either the EAEC virulence plasmid
pCVD432 [6] or the conserved usher gene agg-3C [7] were
performed. That last sample tested positive for EPEC and
two distinct strains of EAEC, EAEC-30-I and EAEC-30-II,
respectively (Fig. 1a, lanes ‘‘stool day 6’’). Both EAEC
isolates were additionally characterized by the pattern of
adherence to HEp-2 as described by Karch et al. [8], and
they showed the ‘‘stacked-brick’’ characteristic of EAEC
(data not shown).
PFGE [9] confirmed that they represented two distinct
isolates (Fig. 1b, lanes ‘‘stool day 6’’). Hence, in total, the
patient was infected by three distinct DECs, one EPEC, and
two EAECs.
Respiratory problems occurred on day 11, and pneu-
mocystis pneumonia was suspected based on radiological
examination. Therapy with trimethoprim–sulfamethoxazole
was started. On day 12, the patient developed progressive
azotemia and a status judged as clearly septic considering
full immunosuppression—as indicated by hypotension (79/
40 mmHg), hypothermia (35.4 C), tachypnea (25/min),
leukocytosis (WBC 33 9 109/l), and a C-reactive protein
(CRP) of 91 mg/l—and was transferred to the intensive care
unit (ICU), where she needed catecholamines for hemody-
namic support. CVVHDF was reinstalled. On day 12, blood
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Fig. 1 Results from polymerase chain reactions (PCRs) aimed at
enteroaggregative Escherichia coli (EAEC) marker genes (a) and
from pulsed-field gel electrophoresis (PFGE) (b) performed using
DNA from purified strains from indicated patient samples. PCRs for
pCVD432 and for agg3C were performed as single reactions, and the
two amplicons were mixed for each strain, including controls, and
electrophoresed as a pool. Lane designations are the same for a and b,
except for the size markers. Br Salmonella serovar Braenderup
standard
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and urine samples tested positive for E. coli using BacT-
Alert and Vitek 2 (bioMe´rieux, Marcy, L’Etoile, France).
Subcultures tested positive by PCR for EAEC marker genes
pCVD432 and agg3C (Fig. 1a, lanes ‘‘urine/blood day 12’’)
and PFGE analysis demonstrated that the isolates from
urine and blood were indistinguishable from the diarrhea-
genic isolate EAEC-30-I (Fig. 1b). This strongly suggested
that isolate EAEC-30-I had colonized the urinary tract and
entered the bloodstream, causing urinary tract infection and
bacteremia leading to sepsis. Meropenem therapy was, thus,
initiated, while trimethoprim–sulfamethoxazole was dis-
continued. Treatment with metronidazole was stopped on
day 20 and meropenem on day 25. The patient was released
on day 26 in a cachectic and weak condition. However,
renal function had resumed on day 14 and diarrhea had
stopped on day 15.
The EAEC stool isolates as well as the EPEC isolate
were characterized by the serotyping of O and H antigens,
performed by using standard methods at the National
Reference Laboratory for Escherichia coli, Federal Insti-
tute for Risk Assessment, Berlin, Germany.
MLST was performed as described by Wirth et al. [10].
Alleles and sequence types (STs) were assigned in accor-
dance with the E. coli MLST website (http://mlst.ucc.ie/).
Furthermore, the isolates were investigated for the pre-
sence of 26 different virulence factors or virulence-asso-
ciated genes harbored by E. coli as described in previous
studies [11, 12] and the results are summarized in Table 1.
All three isolates were subjected to antibiotic suscepti-
bility testing by the disk diffusion method according to
Clinical and Laboratory Standards Institute (CLSI) proto-
cols [13]. The antibiotics (Becton–Dickinson, Sparks, MD,
USA) tested are listed in the footnote to Table 1.
The EPEC isolate belonged to serotype O56:H6 and was
assigned to the allelic profile ST3071. Its virulence profile
was eae, astA, and eilA. Antibiotic susceptibility profiling
revealed a reduced susceptibility to sulfamethoxazole. The
isolate EAEC-30-I belonged to serotype O176:H non-ty-
pable, was assigned to the allelic profile ST3067, and had a
virulence profile of pCVD432, aggR, aap, agg3C, astA,
pic, aaiC, and air. It was resistant to ampicillin, sulfa-
methoxazole, and trimethoprim. Isolate EAEC-30-II was
typed O12:H4, ST484, and carried the virulence genes
pCVD432, aggR, aap, agg4A, sepA, aaiC, and eilA. Its
antibiotic resistance profile included ampicillin, strepto-
mycin, sulfamethoxazole, and trimethoprim.
Discussion
EAEC is an important etiologic agent of diarrhea and
increasingly recognized as a global emerging pathogen and
as a potential threat to public health. However, there are
few studies that explore the role of EAEC in extraintestinal
infections. Recently, EAEC has been confirmed as a
pathogenic agent of urinary tract infections in an outbreak
in Denmark [4]. In a follow up study, the authors reported
that the involved EAEC outbreak strain showed enhanced
adherence to the uroepithelium [14]. Notably, the virulence
gene pic, which is one of the marker genes distinguishing
EAEC-30-I from the diarrheal EAEC-30-II isolate ana-
lyzed in this study, has been described in 95 % of the
strains of this outbreak, as well as in various uropathogenic
E. coli (UPEC) strains [15]. pic has been reported to be a
stimulant of host intestinal mucus secretion as well as to
possess mucinase activity, and is thought to be involved in
Table 1 Characteristics of the enteroaggregative Escherichia coli (EAEC) and enteropathogenic Escherichia coli (EPEC) isolates from the
urinary tract infection (UTI)/sepsis patient
Strain Origin Serotype MLST Virulence or adherence factors STEC/EPEC adherence factors
stx1/2 nleB ETEC-LT ETEC-ST bfpA eae EAF iha saa
EAEC-30 I Stool, urine, blood O176 NT 3067
EAEC-30 II Stool O12 H4 484
EPEC-1327 Stool O56 H6 3071 ?
Strain pAA plasmid Chromosome Resistance profile
Adhesins Toxins
pCVD 432 aggR aap agg3C agg4A aggA aafA astA sat sepA pet pic sigA aaiC air eilA
EAEC-30 I ? ? ? 1 1 1 ? ? AM, SMZ, TMP
EAEC-30 II ? ? ? ? ? ? ? AM, S, SMZ, TMP
EPEC-1327 1 ? SMZ intermediate
Antibiotic disks used for susceptibility testing: AM ampicillin, AMC amoxicillin–clavulanic acid, CF cephalothin, CTX cefotaxime, TZ ceftazidime, CIP
ciprofloxacin, NA nalidixic acid, GM gentamicin, K kanamycin, S streptomycin, TE tetracycline, C chloramphenicol, SMZ sulfamethoxazole, TMP
trimethoprim
NT non-typable
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the process of urinary tract infection in UPEC [16]. Con-
ceivably, pic may be the reason for the dissemination of
EAEC-30-I from the intestine to the urinary tract in our
patient. Further investigation is needed to establish the
possible role of pic as well as other EAEC-specific viru-
lence factors in the uropathogenity of EAEC. Furthermore,
the role of EAEC in urinary tract infections, especially in
catheterized patients and patients with EAEC-associated
diarrhea, warrants increased awareness by clinicians.
In conclusion, this case describes the dissemination of
an EAEC isolate, originating from a mixed intestinal
infection, to the urinary tract and bloodstream of an
immunocompromised, catheterized patient. Finally, we
suggest that certain subtypes of EAEC are both diarrhea-
genic and extraintestinal pathogens, and that their extra-
intestinal virulence potential includes urinary tract
infection as well as bacteremia and sepsis.
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